Issue: Whether the First Circuit Court of Appeals erred when it created a circuit split and held – in clear conflict with this Court’s decisions in PLIVA v. Mensing, Riegel v. Medtronic, and Cipollone v. Liggett Group – that federal law does not preempt state law design-defect claims targeting generic pharmaceutical products because the conceded conflict between such claims and the federal laws governing generic pharmaceutical design allegedly can be avoided if the makers of generic pharmaceuticals simply stop making their products.
On Monday the Court granted five new cases and issued four opinions in argued cases. The archived Live Blog is here.
On Thursday the Justices will meet for their May 23 Conference. Our list of “Petitions to watch” for that Conference is here.
Bloomberg Law and SCOTUSblog’s Supreme Court Challenge
Current Standings - Top 5 Teams
1. The Silent Ts
Georgetown University Law Center
1. Ninos Angels
George Washington University Law School
1. Protect Sam Chase
St. Johns University School of Law
1. Bro Bono
Indiana University -Bloomington, Maurer School of Law
5. Motion to Strike
Cornell University Law School
Click here to learn more